The fertility testing devices market share will post an incremental growth of USD 153.91 million, progressing at a CAGR of 5.73% during the forecast period. The rising median age of first-time pregnancies in women will offer immense growth opportunities to market vendors. The fertility testing devices market is fragmented, and the vendors are deploying growth strategies such as using low-pricing strategies and strengthening the local customer base to compete in the market.
Technavio’s report on “Fertility Testing Devices Market by Product and Geography - Forecast and Analysis 2022-2026” provides a detailed market analysis of the prevalent market forces, trends, and challenges that are likely to impact the market in focus.
The fertility testing devices market is segmented by product (ovulation predictor kits, fertility monitors, and male fertility testing devices) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).
The growth of the fertility testing devices market in the ovulation predictor kits segment will be significant during the forecast period. Factors such as rapid technological advances, and innovations in the development of such kits will facilitate market growth.
By geography, factors such as the rising prevalence of PCOS, the increasing age of first-time pregnancies, and the declining fertility rate in North America will drive the fertility testing devices market size in North America. 40% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for fertility testing devices in North America.
The rising median age of first-time pregnancies in women will directly influence the sales of fertility testing devices. In addition, the easy availability of fertility testing devices on e-commerce sites is one of the major fertility testing devices market trends that will have a positive impact on market growth. However, factors such as the stringent regulatory bodies will hamper the fertility testing devices market growth.
Some of the major fertility testing devices market vendors are Abbott Laboratories, AdvaCare Pharma, Alfa Scientific Designs Inc, Ava AG, Babystart Ltd., bioZhena Corp., Church and Dwight Co. Inc., Geratherm Medical AG, Get Stix Inc., Medical Electronic Systems LLC, Piramal Enterprises Ltd., PREGMATE, Prestige Consumer Healthcare Inc., Quanovate Tech Inc., Quidel Corp., Samplytics Technologies Pvt Ltd., Tempdrop Ltd., The Procter and Gamble Co., UEBE Medical GmbH, and Valley Electronics AG
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
Download the Free PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the growth of the market.
Precise market size estimation during the forecast period 2022-2026.
CAGR of the fertility testing devices market forecast during 2022-2026.
Market-level data on units, average selling prices, and values of the fertility testing devices market share.
Prediction on the upcoming trends, drivers, and factors that challenge the growth of the fertility testing devices market.
Fertility testing devices industry growth across North America, Europe, Asia, and the Rest of the World (ROW).
